Literature DB >> 33778488

Assessing Risk of Breast Cancer: A Review of Risk Prediction Models.

Geunwon Kim1, Manisha Bahl2.   

Abstract

Accurate and individualized breast cancer risk assessment can be used to guide personalized screening and prevention recommendations. Existing risk prediction models use genetic and nongenetic risk factors to provide an estimate of a woman's breast cancer risk and/or the likelihood that she has a BRCA1 or BRCA2 mutation. Each model is best suited for specific clinical scenarios and may have limited applicability in certain types of patients. For example, the Breast Cancer Risk Assessment Tool, which identifies women who would benefit from chemoprevention, is readily accessible and user-friendly but cannot be used in women under 35 years of age or those with prior breast cancer or lobular carcinoma in situ. Emerging research on deep learning-based artificial intelligence (AI) models suggests that mammographic images contain risk indicators that could be used to strengthen existing risk prediction models. This article reviews breast cancer risk factors, describes the appropriate use, strengths, and limitations of each risk prediction model, and discusses the emerging role of AI for risk assessment. © Society of Breast Imaging 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  breast cancer; mammography; risk assessment; screening

Year:  2021        PMID: 33778488      PMCID: PMC7980704          DOI: 10.1093/jbi/wbab001

Source DB:  PubMed          Journal:  J Breast Imaging        ISSN: 2631-6110


  94 in total

1.  Quantitative assessment of mammographic breast density: relationship with breast cancer risk.

Authors:  Jennifer A Harvey; Viktor E Bovbjerg
Journal:  Radiology       Date:  2003-11-14       Impact factor: 11.105

2.  Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

Authors:  Douglas K Owens; Karina W Davidson; Alex H Krist; Michael J Barry; Michael Cabana; Aaron B Caughey; Chyke A Doubeni; John W Epling; Martha Kubik; C Seth Landefeld; Carol M Mangione; Lori Pbert; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

Review 3.  Epidemiology of breast cancer.

Authors:  Kristen A Ban; Constantine V Godellas
Journal:  Surg Oncol Clin N Am       Date:  2014-07       Impact factor: 3.495

4.  Validation studies for models projecting the risk of invasive and total breast cancer incidence.

Authors:  J P Costantino; M H Gail; D Pee; S Anderson; C K Redmond; J Benichou; H S Wieand
Journal:  J Natl Cancer Inst       Date:  1999-09-15       Impact factor: 13.506

5.  Providing access to risk prediction tools via the HL7 XML-formatted risk web service.

Authors:  Jonathan Chipman; Brian Drohan; Amanda Blackford; Giovanni Parmigiani; Kevin Hughes; Phil Bosinoff
Journal:  Breast Cancer Res Treat       Date:  2013-06-23       Impact factor: 4.872

6.  A comparison of methods currently used in clinical practice to estimate familial breast cancer risks.

Authors:  M Tischkowitz; D Wheeler; E France; C Chapman; A Lucassen; J Sampson; P Harper; M Krawczak; J Gray
Journal:  Ann Oncol       Date:  2000-04       Impact factor: 32.976

7.  Validity of models for predicting BRCA1 and BRCA2 mutations.

Authors:  Giovanni Parmigiani; Sining Chen; Edwin S Iversen; Tara M Friebel; Dianne M Finkelstein; Hoda Anton-Culver; Argyrios Ziogas; Barbara L Weber; Andrea Eisen; Kathleen E Malone; Janet R Daling; Li Hsu; Elaine A Ostrander; Leif E Peterson; Joellen M Schildkraut; Claudine Isaacs; Camille Corio; Leoni Leondaridis; Gail Tomlinson; Christopher I Amos; Louise C Strong; Donald A Berry; Jeffrey N Weitzel; Sharon Sand; Debra Dutson; Rich Kerber; Beth N Peshkin; David M Euhus
Journal:  Ann Intern Med       Date:  2007-10-02       Impact factor: 25.391

Review 8.  Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.

Authors:  Emanuele Mazzola; Amanda Blackford; Giovanni Parmigiani; Swati Biswas
Journal:  Cancer Inform       Date:  2015-05-10

9.  Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.

Authors:  Adam R Brentnall; Jack Cuzick; Diana S M Buist; Erin J Aiello Bowles
Journal:  JAMA Oncol       Date:  2018-09-13       Impact factor: 31.777

10.  Incorporating truncating variants in PALB2, CHEK2, and ATM into the BOADICEA breast cancer risk model.

Authors:  Andrew J Lee; Alex P Cunningham; Marc Tischkowitz; Jacques Simard; Paul D Pharoah; Douglas F Easton; Antonis C Antoniou
Journal:  Genet Med       Date:  2016-04-14       Impact factor: 8.822

View more
  4 in total

Review 1.  Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.

Authors:  Touseef Ahmad Qureshi; Sehrish Javed; Tabasom Sarmadi; Stephen Jacob Pandol; Debiao Li
Journal:  Chin Clin Oncol       Date:  2022-02-09

2.  Advances and Future Directions in Molecular Breast Imaging.

Authors:  Matthew F Covington; Ephraim E Parent; Elizabeth H Dibble; Gaiane M Rauch; Amy M Fowler
Journal:  J Nucl Med       Date:  2021-12-09       Impact factor: 11.082

3.  BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme.

Authors:  Jenny Liu; Peh Joo Ho; Tricia Hui Ling Tan; Yen Shing Yeoh; Ying Jia Chew; Nur Khaliesah Mohamed Riza; Alexis Jiaying Khng; Su-Ann Goh; Yi Wang; Han Boon Oh; Chi Hui Chin; Sing Cheer Kwek; Zhi Peng Zhang; Desmond Luan Seng Ong; Swee Tian Quek; Chuan Chien Tan; Hwee Lin Wee; Jingmei Li; Philip Tsau Choong Iau; Mikael Hartman
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

4.  Burden, trends, and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034: an up-to-date overview and comparison with those in Japan and South Korea.

Authors:  Na Liu; Da-Wei Yang; Yan-Xia Wu; Wen-Qiong Xue; Dan-Hua Li; Jiang-Bo Zhang; Yong-Qiao He; Wei-Hua Jia
Journal:  BMC Cancer       Date:  2022-07-29       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.